Tanuja Joshi Selected Research

Proteins (Proteins, Gene)

1/2023	In silico screening of natural compounds to inhibit interaction of human ACE2 receptor and spike protein of SARS-CoV-2 for the prevention of COVID-19.
1/2022	Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tanuja Joshi Research Topics

Disease

8	COVID-19 01/2023 - 08/2021
1	Malaria 10/2023
1	Leishmaniasis 07/2023
1	Infections 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Severe Acute Respiratory Syndrome 01/2022
1	Diabetes Mellitus 10/2021
1	Myocardial Infarction 08/2020
1	Type 2 Diabetes Mellitus (MODY) 02/2020

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 08/2022 - 10/2021
2	PhytochemicalsIBA 01/2023 - 02/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	VaccinesIBA 01/2022 - 10/2021
2	SARS-CoV-2 3C-like proteinaseIBA 12/2021 - 08/2021
1	odorant-binding proteinIBA 10/2023
1	Antimalarials (Antimalarial Agents)IBA 10/2023
1	Carrier Proteins (Binding Protein)IBA 10/2023
1	Volatile Oils (Essential Oils)IBA 10/2023
1	LigandsIBA 07/2023
1	AngiotensinsIBA 01/2023
1	Chymases (Chymase)IBA 08/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Cimetidine (Biomet)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	ZincIBA 01/2022
1	Famotidine (Pepcid)FDA LinkGeneric 01/2022
1	Amylases FDA Link 10/2021
1	Glycoside Hydrolases (Endoglycosidases)IBA 10/2021
1	SARS coronavirus 3C-like proteaseIBA 08/2021
1	Therapeutic UsesIBA 08/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2020

Therapy/Procedure

1	Therapeutics 10/2023